Simon Tate
CIK 1867441 · View on SEC EDGAR ↗
Insider
First SEC filing: Aug. 9, 2021 · Latest: Aug. 9, 2021
On this page
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 3 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| May 18, 2023 | CLYM | A | 10,000 | — | — | 10,000 Direct | — | Acquired | (price as of 2026-08-19) |
| May 19, 2022 | CLYM | A | 10,000 | — | — | 10,000 Direct | — | Acquired | (price as of 2026-08-19) |
| Aug. 9, 2021 | CLYM | A | 20,000 | — | — | 20,000 Direct | — | Acquired | (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| May 18, 2023 | CLYM | Stock Option (Right To Buy) | Common Stock (10,000) | $3.00 | May 17, 2033 | 10,000 | Acquired |
| May 19, 2022 | CLYM | Stock Option (Right To Buy) | Common Stock (10,000) | $3.46 | May 18, 2032 | 10,000 | Acquired |
| Aug. 9, 2021 | CLYM | Stock Option (Right to Buy) | Common Stock (20,000) | $12.50 | Aug. 8, 2031 | 20,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Aug. 9, 2021 | CLYM | No securities are beneficially owned. | 0 | Direct |